Cytek Biosciences, Inc. (CTKB) Stock Price & Analysis

Cytek Biosciences, Inc. (CTKB) rose 0.00% to USD 4.7 as of September 8, 2026 at 05:04 UTC, according to Nexqual real-time market data.

CTKB last closed at USD 4.7; the session ranged USD 4.62–4.73 on volume of 478,226 shares. Market capitalization is —, with a 52-week range of USD 3.28–6.18 (NMS). Source: Nexqual, September 8, 2026 at 05:04 UTC.

Key Statistics (as of September 8, 2026 at 05:04 UTC)

Technical Analysis (CTKB)

Nexqual's technical model rates CTKB "STRONG BUY" based on 5 bullish and 0 bearish signals across 128 daily candles, as of September 8, 2026 at 05:04 UTC.

From Cytek Biosciences, Inc.'s Latest SEC 10-K Filing (filed 2026-02-26)

Key Strengths & Strategy (as disclosed to the SEC)

• Each system is supported by our highly intuitive, proprietary embedded SpectroFlo ® software, our reagents, and our service offerings to provide a comprehensive, end-to-end platform of solutions for our customers.
• In addition to pursuing patents on our technology, we have taken steps to protect our intellectual property and proprietary technology by entering into confidentiality agreements and intellectual property assignment agreements with our employees, consultants, corporate partners and, when needed, our advisors.
• For example, we utilize both instructor-led training and online learning to deliver proprietary, targeted training courses designed to position our commercial organization as the leading cell analysis solutions provider.
• Our proprietary tools and the intuitive functionality of our proprietary SpectroFlo software coupled with a user-friendly interface allow for enhanced ease-of-use and minimal operator training.

Partnerships

• On October 6, 2020, we entered into a Settlement, License and Equity Issuance Agreement with BD pursuant to which we and BD agreed to a mutual release of all claims against each other as of the date thereof (the "BD Agreement").
• Our Panel Builder tool combines all the features of the Full Spectrum Viewer with additional tools for panel design and collaboration in a simple and organized interface.

Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.

Peers & Related Stocks

Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 05:04 UTC. This page is informational and not investment advice.